Anxiety (GAD-7), depression (PHQ-9) and treatment adherence (CFHH) pre- and during the COVID-19 pandemic
| Assessment | Pre-COVID | During COVID | Difference | |
|---|---|---|---|---|
| GAD-7 (n=41) | Median [IQR] | 2 [0.5–6] | 5 [1–11] | +3* |
| Sub-clinical (%) | 73 | 46 | –27 | |
| Mild (%) | 7.3 | 27 | +20 | |
| Moderate (%) | 12 | 15 | +2.4 | |
| Severe (%) | 7.3 | 12 | +4.8 | |
| ‘Clinical’ (mild-severe; %) | 27 | 54 | +27 | |
| PHQ-9 (n=43) | Median [IQR] | 3 [1–10] | 3 [2–12] | 0† |
| Sub-Clinical (%) | 53 | 53 | 0 | |
| Mild (%) | 21 | 16 | –4.7 | |
| Moderate (%) | 9.3 | 9.3 | 0 | |
| Moderate-severe (%) | 16 | 14 | –2.3 | |
| Severe (%) | 0 | 7 | +7 | |
| ‘Clinical’ (mild-severe; %) | 47 | 47 | 0 | |
| CFHH Adherence (n=28) (mean %) | 80% | 87% | +7%† | |